|
1
|
Siegel RL, Giaquinto AN and Jemal A:
Cancer statistics, 2024. CA Cancer J Clin. 74:12–49.
2024.PubMed/NCBI
|
|
2
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
3
|
Bade BC and Dela Cruz CS: Lung cancer
2020: Epidemiology, etiology, and prevention. Clin Chest Med.
41:1–24. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hirsch FR, Scagliotti GV, Mulshine JL,
Kwon R, Curran WJ Jr, Wu YL and Paz-Ares L: Lung cancer: Current
therapies and new targeted treatments. Lancet. 389:299–311. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Duma N, Santana-Davila R and Molina JR:
Non-Small cell lung cancer: Epidemiology, screening, diagnosis, and
treatment. Mayo Clin Proc. 94:1623–1640. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Friedlaender A, Addeo A, Russo A, Gregorc
V, Cortinovis D and Rolfo CD: Targeted therapies in early stage
NSCLC: Hype or hope? Int J Mol Sci. 21:63292020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park E, Hong K, Kwon BM, Kim Y and Kim JH:
Jaceosidin ameliorates insulin resistance and kidney dysfunction by
enhancing insulin receptor signaling and the antioxidant defense
system in type 2 diabetic mice. J Med Food. 23:1083–1092. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nageen B, Rasul A, Hussain G, Shah MA,
Anwar H, Hussain SM, Uddin MS, Sarfraz I, Riaz A and Selamoglu Z:
Jaceosidin: A natural flavone with versatile pharmacological and
biological activities. Curr Pharm Des. 27:456–466. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee HG, Yu KA, Oh WK, Baeg TW, Oh HC, Ahn
JS, Jang WC, Kim JW, Lim JS, Choe YK and Yoon DY: Inhibitory effect
of jaceosidin isolated from Artemisiaargyi on the function of E6
and E7 oncoproteins of HPV 16. J Ethnopharmacol. 98:339–343. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Woo SM and Kwon TK: Jaceosidin induces
apoptosis through Bax activation and down-regulation of Mcl-1 and
c-FLIP expression in human renal carcinoma Caki cells. Chem Biol
Interact. 260:168–175. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim MJ, Kim DH, Lee KW, Yoon DY and Surh
YJ: Jaceosidin induces apoptosis in ras-transformed human breast
epithelial cells through generation of reactive oxygen species. Ann
N Y Acad Sci. 1095:483–495. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jeong MA, Lee KW, Yoon DY and Lee HJ:
Jaceosidin, a pharmacologically active flavone derived from
Artemisia argyi, inhibits phorbol-ester-induced upregulation of
COX-2 and MMP-9 by blocking phosphorylation of ERK-1 and −2 in
cultured human mammary epithelial cells. Ann N Y Acad Sci.
1095:458–466. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Khan M, Yu B, Rasul A, Al Shawi A, Yi F,
Yang H and Ma T: Jaceosidin induces apoptosis in U87 glioblastoma
cells through G2/M phase arrest. Evid Based Complement Alternat
Med. 2012:7030342012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Khan M, Rasul A, Yi F, Zhong L and Ma T:
Jaceosidin induces p53-dependent G2/M phase arrest in U87
glioblastoma cells. Asian Pac J Cancer Prev. 12:3235–3238.
2011.PubMed/NCBI
|
|
15
|
Nagasaka M and Gadgeel SM: Role of
chemotherapy and targeted therapy in early-stage non-small cell
lung cancer. Expert Rev Anticancer Ther. 18:63–70. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang Y, Li N, Wang TM and Di L: Natural
products with activity against lung cancer: A review focusing on
the tumor microenvironment. Int J Mol Sci. 22:108272021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wen T, Song L and Hua S: Perspectives and
controversies regarding the use of natural products for the
treatment of lung cancer. Cancer Med. 10:2396–2422. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Z: Regulation of cell cycle
progression by growth Factor-induced cell signaling. Cells.
10:33272021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yan W, Wu THY, Leung SSY and To KKW:
Flavonoids potentiated anticancer activity of cisplatin in
non-small cell lung cancer cells in vitro by inhibiting histone
deacetylases. Life Sci. 258:1182112020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pani S, Mohapatra S, Sahoo A, Baral B and
Debata PR: Shifting of cell cycle arrest from the S-phase to G2/M
phase and downregulation of EGFR expression by phytochemical
combinations in HeLa cervical cancer cells. J Biochem Mol Toxicol.
36:e229472022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim IH, Eom T, Park JY, Kim HJ and Nam TJ:
Dichloromethane fractions of Calystegia soldanella induce
S-phase arrest and apoptosis in HT-29 human colorectal cancer
cells. Mol Med Rep. 25:602022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li J, Yuan J, Li Y, Wang J, Gong D, Xie Q,
Ma R, Wang J, Ren M, Lu D and Xu Z: d-Borneol enhances cisplatin
sensitivity via p21/p27-mediated S-phase arrest and cell apoptosis
in non-small cell lung cancer cells and a murine xenograft model.
Cell Mol Biol Lett. 27:612022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shamloo B and Usluer S: p21 in cancer
research. Cancers (Basel). 11:11782019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pistritto G, Trisciuoglio D, Ceci C,
Garufi A and D'Orazi G: Apoptosis as anticancer mechanism: Function
and dysfunction of its modulators and targeted therapeutic
strategies. Aging (Albany NY). 8:603–619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang X, Yang X, Chen M, Zheng S, Li J,
Lin S and Wang X: ST3Gal3 confers paclitaxel-mediated
chemoresistance in ovarian cancer cells by attenuating caspase-8/3
signaling. Mol Med Rep. 20:4499–4506. 2019.PubMed/NCBI
|
|
26
|
Ramadhani FJ, Kang SH, Kawala RA, Chung
BY, Bai HW and Kang BS: γ-irradiated prednisolone promotes
apoptosis of liver cancer cells via activation of intrinsic
apoptosis signaling pathway. Mol Med Rep. 23:4252021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jin N, Xia Y and Gao Q: Combined PARP
inhibitors and small molecular inhibitors in solid tumor treatment
(review). Int J Oncol. 62:282023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Santagostino SF, Assenmacher CA, Tarrant
JC, Adedeji AO and Radaelli E: Mechanisms of regulated cell death:
Current perspectives. Vet Pathol. 58:596–623. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim BI, Kim JH, Sim DY, Nam M, Jung JH,
Shim B, Lee J and Kim SH: Inhibition of JAK2/STAT3 and activation
of caspase-9/3 are involved in KYS05090S-induced apoptosis in
ovarian cancer cells. Int J Oncol. 55:203–210. 2019.PubMed/NCBI
|
|
30
|
Han HY, Kim HJ, Jeong SH, Kim J, Jeong SH,
Kim GC, Hwang DS, Kim UK and Ryu MH: The flavonoid jaceosidin from
artemisia princeps induces apoptotic cell death and inhibits the
Akt pathway in oral cancer cells. Evid Based Complement Alternat
Med. 2018:57650472018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Warren CFA, Wong-Brown MW and Bowden NA:
BCL-2 family isoforms in apoptosis and cancer. Cell Death Dis.
10:1772019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang Y, Xia C, Lun Z, Lv Y, Chen W and Li
T: Crosstalk between p38 MAPK and caspase-9 regulates
mitochondria-mediated apoptosis induced by
tetra-α-(4-carboxyphenoxy) phthalocyanine zinc photodynamic therapy
in LoVo cells. Oncol Rep. 39:61–70. 2018.PubMed/NCBI
|
|
33
|
Lv W, Sheng X, Chen T, Xu Q and Xie X:
Jaceosidin induces apoptosis in human ovary cancer cells through
mitochondrial pathway. J Biomed Biotechnol.
2008:3948022008.PubMed/NCBI
|
|
34
|
Korzeniecki C and Priefer R: Targeting
KRAS mutant cancers by preventing signaling transduction in the
MAPK pathway. Eur J Med Chem. 211:1130062021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Barbosa R, Acevedo LA and Marmorstein R:
The MEK/ERK network as a therapeutic target in human cancer. Mol
Cancer Res. 19:361–374. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tan AC: Targeting the PI3K/Akt/mTOR
pathway in non-small cell lung cancer (NSCLC). Thorac Cancer.
11:511–518. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Takeda T, Yamamoto Y, Tsubaki M, Matsuda
T, Kimura A, Shimo N and Nishida S: PI3K/Akt/YAP signaling promotes
migration and invasion of DLD-1 colorectal cancer cells. Oncol
Lett. 23:1062022. View Article : Google Scholar : PubMed/NCBI
|
